Literature DB >> 17549374

VEGF-C, VEGFR-3, and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro.

Xiaoyan Shi1, Gang Chen, Hui Xing, Danhui Weng, Xiangyang Bai, Ding Ma.   

Abstract

The study was conducted to clarify the expression and biological significance of VEGF-C and VEGFR-3 in human cervical cancer cell lines and to investigate the correlation between VEGF-C and cyclooxygenase-2 (COX-2) expression in these cells. Flow cytometry, Western blotting, RT-PCR, cell immunochemistry assay, cell proliferation assay, in vitro invasion assay and cell immunochemistry assay were used to detect the gene expression and to evaluate the biological features in test cell lines. VEGF-C expression was low while VEGFR-3 was quiet high in all cell lines detected. COX-2 expression coincided with that of VEGF-C. Recombinant human VEFG-C-treated HeLa cells showed increased proliferation and invasion in a dose-depended manner while NS398, a specific inhibitor of COX-2, blocked the invasive ability of HeLa. VEGF-C and its VEGFR-3 played a crucial role in the regulation of tumor growth and metastasis in cervical cell lines, and COX-2 might be a regulator of VEGF-C expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549374

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Soluble Production of Human Recombinant VEGF-A121 by Using SUMO Fusion Technology in Escherichia coli.

Authors:  Rufus Vinod Munawar Samuel; Syeda Yumna Farrukh; Sadia Rehmat; Muhammad Umair Hanif; Syed Shoaib Ahmed; Syed Ghulam Musharraf; Faiza Gul Durrani; Mahjabeen Saleem; Roquyya Gul
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

2.  Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.

Authors:  Feng Gao; Zhijun Sun; Xin Sun; Yonghua Zhang; Hong Wang; Biao Zhong; Jie Luo; Xiaoliang Zhao
Journal:  Cancer Biother Radiopharm       Date:  2013-03-11       Impact factor: 3.099

3.  RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.

Authors:  Jibin Yao; Mingxu Da; Tiankang Guo; Yaoxing Duan; Yongbin Zhang
Journal:  Tumour Biol       Date:  2013-03-10

4.  RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.

Authors:  Ping Sun; Jie Gao; Yan-Li Liu; Lu-Wan Wei; Li-Ping Wu; Zhi-Yu Liu
Journal:  Mol Cell Biochem       Date:  2007-10-16       Impact factor: 3.396

Review 5.  Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

Authors:  Ming-Chuan Hsu; Mei-Ren Pan; Wen-Chun Hung
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

6.  Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB.

Authors:  Magdalena Franc; Agata Kachel-Flis; Bogdan Michalski; Anna Fila-Daniłow; Urszula Mazurek; Mateusz Michalski; Anna Michalska; Ilona Kuczerawy; Violetta Skrzypulec-Plinta
Journal:  Prz Menopauzalny       Date:  2015-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.